SCHEMBL21513680

SCHEMBL21513680

COC(=O)C1CC(O)(c2cccc(OC)n2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.41
OPRL1 P41146 3/20 0.41
CCR2 P41597 2/20 0.38
KCNH2 Q12809 2/20 0.38
SLC6A9 P48067 2/20 0.36
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
CCRL2 O00421 1/20 0.35
KDM1A O60341 1/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
HTR1A P08908 1/20 0.34
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
SORT1 Q99523 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29969932 1.00 OPRM1 (0.41) OPRM1OPRL1CCR2KCNH2SLC6A9
SCHEMBL21513711 0.85 OPRM1 (0.40) OPRM1OPRL1CCR2KCNH2SLC6A9
SCHEMBL29969129 0.85 OPRM1 (0.40) OPRM1OPRL1CCR2KCNH2SLC6A9
SCHEMBL29970107 0.77 SLC6A2 (0.42) OPRM1OPRL1HTR1ANPC1RAB9A
SCHEMBL21512759 0.77 SLC6A2 (0.42) OPRM1OPRL1HTR1ANPC1RAB9A
SCHEMBL2591922 0.76 DDB1 (0.39) OPRM1OPRL1CCR2KCNH2DDB1
SCHEMBL23231745 0.74 HTR2A (0.43) OPRM1OPRL1CCR2KCNH2SLC6A9
SCHEMBL2483670 0.72 DDB1 (0.41) CCR2KCNH2SLC6A9DDB1CRBN
SCHEMBL21512768 0.72 NNMT (0.41) CCR2KCNH2MAPTNPC1RAB9A
SCHEMBL29969530 0.72 NNMT (0.41) CCR2KCNH2MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4327877-A2 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRad Therapeutics, Inc. (US) 2024-02-28 EP disclosed
EP-4327877-A2 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRad Therapeutics, Inc. (US) 2024-02-28 EP disclosed
EP-3784671-B1 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRAD THERAPEUTICS INC (US) 2023-10-11 EP disclosed
EP-3784671-B1 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRAD THERAPEUTICS INC (US) 2023-10-11 EP disclosed
WO-2019201283-A1 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRAD THERAPEUTICS, INC. (US) 2019-10-24 WO disclosed